T1	Participants 68 161	intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia
T2	Participants 351 458	younger patients with nonacute promyelocytic acute myeloid leukemia and high-risk myelodysplastic syndrome,
T3	Participants 537 576	1075 patients less than 60 years of age
